ArticlePloS one2011
Optimization based tumor classification from microarray gene expression data.
Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- DNA sequence analysis landscape: a comprehensive review of DNA sequence analysis task types, databases, datasets, word embedding methods, and language models.Frontiers in medicine · 2025Review
- A Dual Level Analysis with Evolutionary Computing and Swarm Models for Classification of Leukemia.BioMed research international · 2022Article
- Structure-based design and classifications of small molecules regulating the circadian rhythm period.Scientific reports · 2021Article
- Optimizing ANFIS using simulated annealing algorithm for classification of microarray gene expression cancer data.Medical & biological engineering & computing · 2021Article
- Feature Selection and Cancer Classification via Sparse Logistic Regression with the Hybrid L1/2 +2 Regularization.PloS one · 2016Article
- A Unified Framework for Reservoir Computing and Extreme Learning Machines based on a Single Time-delayed Neuron.Scientific reports · 2015Article
- Multi-class BCGA-ELM based classifier that identifies biomarkers associated with hallmarks of cancer.BMC bioinformatics · 2015Article
- Pathway activity inference for multiclass disease classification through a mathematical programming optimisation framework.BMC bioinformatics · 2014Article
- Feature weight estimation for gene selection: a local hyperlinear learning approach.BMC bioinformatics · 2014Article
- Copy number variation analysis based on AluScan sequences.Journal of clinical bioinformatics · 2014Article
- A comparative analysis of swarm intelligence techniques for feature selection in cancer classification.TheScientificWorldJournal · 2014Article
- Comprehensive evaluation of composite gene features in cancer outcome prediction.Cancer informatics · 2014Article
- Application of Machine Learning to Development of Copy Number Variation-based Prediction of Cancer Risk.Genomics insights · 2014Article
- Improved classification of lung cancer tumors based on structural and physicochemical properties of proteins using data mining models.PloS one · 2013Article
- Applications of Bayesian gene selection and classification with mixtures of generalized singular g-priors.Computational and mathematical methods in medicine · 2013Article
- Class prediction and feature selection with linear optimization for metagenomic count data.PloS one · 2013Article
- Improving accuracy for cancer classification with a new algorithm for genes selection.BMC bioinformatics · 2012Article
- SPICE: discovery of phenotype-determining component interplays.BMC systems biology · 2012Article
- Functional network construction in Arabidopsis using rule-based machine learning on large-scale data sets.The Plant cell · 2011Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn important use of data obtained from microarray measurements is the classification of tumor types with respect to genes that are either up or down regulated in specific cancer types. A number of algorithms have been proposed to obtain such classifications. These algorithms usually require parameter optimization to obtain accurate results depending on the type of data. Additionally, it is highly critical to find an optimal set of markers among those up or down regulated genes that can be clinically utilized to build assays for the diagnosis or to follow progression of specific cancer types. In this paper, we employ a mixed integer programming based classification algorithm named hyper-box enclosure method (HBE) for the classification of some cancer types with a minimal set of predictor genes. This optimization based method which is a user friendly and efficient classifier may allow the clinicians to diagnose and follow progression of certain cancer types. METHODOLOGY/PRINCIPAL
findingsWe apply HBE algorithm to some well known data sets such as leukemia, prostate cancer, diffuse large B-cell lymphoma (DLBCL), small round blue cell tumors (SRBCT) to find some predictor genes that can be utilized for diagnosis and prognosis in a robust manner with a high accuracy. Our approach does not require any modification or parameter optimization for each data set. Additionally, information gain attribute evaluator, relief attribute evaluator and correlation-based feature selection methods are employed for the gene selection. The results are compared with those from other studies and biological roles of selected genes in corresponding cancer type are described. CONCLUSIONS/SIGNIFICANCE: The performance of our algorithm overall was better than the other algorithms reported in the literature and classifiers found in WEKA data-mining package. Since it does not require a parameter optimization and it performs consistently very high prediction rate on different type of data sets, HBE method is an effective and consistent tool for cancer type prediction with a small number of gene markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.